Insider Activity of FREEMAN KEVIN D
According to the SEC Form 4 filings, FREEMAN KEVIN D, being in a position of
- director at Galectin Therapeutics Inc.,оver the last 12 months, has bought 5500 shares for $19,514, and sold 0 shares,over all time since 2013-05-28, has bought 149192 shares for $374,619, and sold 0 shares.
Biography of FREEMAN KEVIN D
No biography is available at this moment.